Literature DB >> 16704373

The histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway.

Sara Sánchez-Molina1, José Luis Oliva, Susana García-Vargas, Ester Valls, José M Rojas, Marian A Martínez-Balbás.   

Abstract

The CBP [CREB (cAMP-response-element-binding protein)-binding protein]/p300 acetyltransferases function as transcriptional co-activators and play critical roles in cell differentiation and proliferation. Accumulating evidence shows that alterations of the CBP/p300 protein levels are linked to human tumours. In the present study, we show that the levels of the CBP/p300 co-activators are decreased dramatically by continuous PDGF (platelet-derived growth factor) and Ras signalling pathway activation in NIH 3T3 fibroblasts. This effect occurs by reducing the expression levels of the CBP/p300 genes. In addition, CBP and p300 are degraded by the 26 S proteasome pathway leading to an overall decrease in the levels of the CBP/p300 proteins. Furthermore, we provide evidence that Mdm2 (murine double minute 2), in the presence of active H-Ras or N-Ras, induces CBP/p300 degradation in NIH 3T3 cells. These findings support a novel mechanism for modulating other signalling transduction pathways that require these common co-activators.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704373      PMCID: PMC1550303          DOI: 10.1042/BJ20060052

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  59 in total

1.  Mutations truncating the EP300 acetylase in human cancers.

Authors:  S A Gayther; S J Batley; L Linger; A Bannister; K Thorpe; S F Chin; Y Daigo; P Russell; A Wilson; H M Sowter; J D Delhanty; B A Ponder; T Kouzarides; C Caldas
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 2.  Understanding Ras: 'it ain't over 'til it's over'.

Authors:  J M Shields; K Pruitt; A McFall; A Shaub; C J Der
Journal:  Trends Cell Biol       Date:  2000-04       Impact factor: 20.808

Review 3.  DNA tumor virus transforming proteins and the cell cycle.

Authors:  E Moran
Journal:  Curr Opin Genet Dev       Date:  1993-02       Impact factor: 5.578

4.  H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway.

Authors:  A Apolloni; I A Prior; M Lindsay; R G Parton; J F Hancock
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

5.  Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP.

Authors:  A L Kung; V I Rebel; R T Bronson; L E Ch'ng; C A Sieff; D M Livingston; T P Yao
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

6.  Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

Authors:  Juan M Alarcón; Gaël Malleret; Khalid Touzani; Svetlana Vronskaya; Shunsuke Ishii; Eric R Kandel; Angel Barco
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

7.  MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.

Authors:  Yetao Jin; Shelya X Zeng; Hunjoo Lee; Hua Lu
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

8.  The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.

Authors:  José Luis Oliva; Natasha Zarich; Natalia Martínez; Rocío Jorge; Antonio Castrillo; Marta Azañedo; Susana García-Vargas; Silvia Gutiérrez-Eisman; Angeles Juarranz; Lisardo Boscá; J Silvio Gutkind; José M Rojas
Journal:  J Biol Chem       Date:  2004-06-04       Impact factor: 5.157

Review 9.  p300/CBP and cancer.

Authors:  Narayanan Gopalakrishna Iyer; Hilal Ozdag; Carlos Caldas
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

10.  A direct link between core histone acetylation and transcriptionally active chromatin.

Authors:  T R Hebbes; A W Thorne; C Crane-Robinson
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more
  13 in total

1.  Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.

Authors:  Gabriel J Villares; Maya Zigler; Andrey S Dobroff; Hua Wang; Renduo Song; Vladislava O Melnikova; Li Huang; Russell R Braeuer; Menashe Bar-Eli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 2.  Regulation of histone modifying enzymes by the ubiquitin-proteasome system.

Authors:  Chunbin Zou; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2014-01-03

Review 3.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

4.  The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity.

Authors:  Erin A Kimbrel; Andrew L Kung
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

5.  Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts.

Authors:  Laurence Goffin; Queralt Seguin-Estévez; Montserrat Alvarez; Walter Reith; Carlo Chizzolini
Journal:  Arthritis Res Ther       Date:  2010-04-29       Impact factor: 5.156

6.  Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells.

Authors:  Shambhunath Choudhary; Hwa-Chain Robert Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

7.  Screening E3 substrates using a live phage display library.

Authors:  Zhengguang Guo; Xiaorong Wang; Huihua Li; Youhe Gao
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  SUMOylation regulates the nuclear mobility of CREB binding protein and its association with nuclear bodies in live cells.

Authors:  Colm M Ryan; Karin B Kindle; Hilary M Collins; David M Heery
Journal:  Biochem Biophys Res Commun       Date:  2009-12-16       Impact factor: 3.575

9.  Oncogene Ras/phosphatidylinositol 3-kinase signaling targets histone H3 acetylation at lysine 56.

Authors:  Yan Liu; Da-Liang Wang; Su Chen; Lei Zhao; Fang-Lin Sun
Journal:  J Biol Chem       Date:  2012-09-16       Impact factor: 5.157

10.  The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53.

Authors:  Alberto Valbuena; Sandra Blanco; Francisco M Vega; Pedro A Lazo
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.